LifeMD Statistics
Total Valuation
LifeMD has a market cap or net worth of $181.47 million. The enterprise value is $164.21 million.
Important Dates
The next estimated earnings date is Monday, March 9, 2026, after market close.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LifeMD has 48.14 million shares outstanding. The number of shares has increased by 10.44% in one year.
| Current Share Class | 48.14M |
| Shares Outstanding | 48.14M |
| Shares Change (YoY) | +10.44% |
| Shares Change (QoQ) | +3.90% |
| Owned by Insiders (%) | 15.07% |
| Owned by Institutions (%) | 42.31% |
| Float | 39.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| Forward PS | 0.85 |
| PB Ratio | 133.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.97 |
| P/OCF Ratio | 14.36 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 15.36 |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.94.
| Current Ratio | 0.73 |
| Quick Ratio | 0.58 |
| Debt / Equity | 1.94 |
| Debt / EBITDA | 22.45 |
| Debt / FCF | 0.61 |
| Interest Coverage | -1.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -2.85% |
| Return on Invested Capital (ROIC) | -13.57% |
| Return on Capital Employed (ROCE) | -33.89% |
| Revenue Per Employee | $814,631 |
| Profits Per Employee | -$36,245 |
| Employee Count | 307 |
| Asset Turnover | 3.61 |
| Inventory Turnover | 10.83 |
Taxes
In the past 12 months, LifeMD has paid $338,611 in taxes.
| Income Tax | 338,611 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.06% in the last 52 weeks. The beta is 1.45, so LifeMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -23.06% |
| 50-Day Moving Average | 3.93 |
| 200-Day Moving Average | 7.31 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 1,302,113 |
Short Selling Information
The latest short interest is 5.10 million, so 10.60% of the outstanding shares have been sold short.
| Short Interest | 5.10M |
| Short Previous Month | 5.05M |
| Short % of Shares Out | 10.60% |
| Short % of Float | 13.02% |
| Short Ratio (days to cover) | 4.07 |
Income Statement
In the last 12 months, LifeMD had revenue of $250.09 million and -$11.13 million in losses. Loss per share was -$0.25.
| Revenue | 250.09M |
| Gross Profit | 217.18M |
| Operating Income | -3.16M |
| Pretax Income | -6.48M |
| Net Income | -11.13M |
| EBITDA | -1.36M |
| EBIT | -3.16M |
| Loss Per Share | -$0.25 |
Full Income StatementBalance Sheet
The company has $23.79 million in cash and $6.53 million in debt, with a net cash position of $17.26 million or $0.36 per share.
| Cash & Cash Equivalents | 23.79M |
| Total Debt | 6.53M |
| Net Cash | 17.26M |
| Net Cash Per Share | $0.36 |
| Equity (Book Value) | 3.37M |
| Book Value Per Share | 0.03 |
| Working Capital | -15.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.63 million and capital expenditures -$1.94 million, giving a free cash flow of $10.69 million.
| Operating Cash Flow | 12.63M |
| Capital Expenditures | -1.94M |
| Free Cash Flow | 10.69M |
| FCF Per Share | $0.22 |
Full Cash Flow StatementMargins
Gross margin is 86.84%, with operating and profit margins of -1.26% and -3.21%.
| Gross Margin | 86.84% |
| Operating Margin | -1.26% |
| Pretax Margin | -2.59% |
| Profit Margin | -3.21% |
| EBITDA Margin | -0.54% |
| EBIT Margin | -1.26% |
| FCF Margin | 4.28% |
Dividends & Yields
LifeMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.44% |
| Shareholder Yield | -10.44% |
| Earnings Yield | -6.13% |
| FCF Yield | 5.89% |
Analyst Forecast
The average price target for LifeMD is $10.22, which is 171.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.22 |
| Price Target Difference | 171.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 2.83% |
| EPS Growth Forecast (5Y) | -55.78% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 14, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Oct 14, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
LifeMD has an Altman Z-Score of 1.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.17 |
| Piotroski F-Score | 3 |
